Value of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis.

Efficacy and Safety of Bronchoalveolar Lavage with Acetylcysteine in the Treatment of Bronchiectasis with Infection in Adults: a Multicentre, Blinded, Randomised Controlled Study.

NCT06726356•First Affiliated Hospital of Ningbo University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Bronchiectasis with Acute Exacerbation

Interventions

Bronchoalveolar Lavage

Locations

China

Locations (1)

The First Affiliated Hospital of Ningbo University

Ningbo, Zhejiang, China

Key Dates

Start Date

August 14, 2024

Primary Completion Date

July 30, 2025

Completion Date

July 30, 2026

Last Updated

December 10, 2024

Contacts

Zhongbo Chen

CONTACT

13777125910 leonczb@163.com

Sponsors

Lead Sponsor

First Affiliated Hospital of Ningbo University

Collaborators

Shenzhen Third People's Hospital
Anhui Chest Hospital
Ninghai First Hospital
Jingzhou Central Hospital

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 10, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions